logo

For the Inventor, By the Inventor

Wuppertal-Elberfeld, Germany

Hans-Bodo Konig

USPTO Granted Patents = 34

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 142(Granted Patents)


Location History:

  • Wuppertal-Elberfeld, DE (1976 - 1977)
  • Wuppertal, DE (1976 - 1983)

Company Filing History:

goldMedal34 out of 12,160 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1976-1983

Loading Chart...
34 patents (USPTO):Explore Patents
1. 4386089 - .beta.-Lactam antibiotics and their medicinal use (1983-05-31),
2. 4344955 - Penicillin 1,1-dioxides (1982-08-17),
3. 4344939 - Penicillin 1,1-dioxides, compositions thereof and methods of use (1982-08-17),
4. 4338434 - 2-Hetero-acetamido-cephalosporinates (1982-07-06),
5. 4235774 - Penicillin derivatives (1980-11-25),
6. 4218451 - Penicillins and their use (1980-08-19),
7. 4215118 - 2-Hetero-acetamido-penicillanates and cephalosporinates (1980-07-29),
8. 4147693 - .beta.Lactam antibiotics and process for their use (1979-04-03),
9. 4107304 - Oxo-imidazolidine substituted cephalosporins and antibacterial (1978-08-15),
10. 4093722 - Sulfonylimidazolidone substituted cephalosporins, antibacterial (1978-06-06),
11. 4086340 - Cephalosporins and their production (1978-04-25),
12. 4081539 - Penicillins and cephalosporins and their production (1978-03-28),
13. 4071683 - Oxoimidazolidinylthiocarbonyl derivatives of ceph-3-em-4-carboxylic acids (1978-01-31),
14. 4039673 - Penicillins and cephalosporins and their production (1977-08-02),
15. 4031229 - Penicillins and processes for their preparation and use (1977-06-21),

Title: Innovations and Contributions of Hans-Bodo Konig

Introduction

Hans-Bodo Konig, a prominent inventor located in Wuppertal-Elberfeld, Germany, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 34 patents, his work primarily revolves around the development and application of beta-lactam antibiotics, which are crucial in treating bacterial infections.

Latest Patents

Among Hans-Bodo Konig's latest patents, two stand out for their medical implications:

1. **Beta-lactam antibiotics and their medicinal use** - This patent details beta-lactam compounds characterized by a formula in which B denotes an optionally substituted heterocyclic 5-membered or 6-membered ring or an optionally substituted phenyl ring.

2. **Penicillin 1,1-dioxides** - This invention covers anti-bacterially active penicillin 1,1-dioxides or a salt thereof, with R1 representing either a hydrogen atom or an ester-forming radical.

Career Highlights

Hans-Bodo Konig is associated with Bayer Aktiengesellschaft, a leading company in the pharmaceutical industry known for its commitment to research and innovation. His extensive experience and focus on antibiotic discovery are a testament to his impactful contributions to medicine.

Collaborations

Throughout his career, Konig has collaborated with notable colleagues such as Wilfried Schrock and Karl G Metzger. Their collective expertise has fostered an environment of innovation, leading to advancements in antibacterial agents and their therapeutic applications.

Conclusion

Hans-Bodo Konig is a key figure in pharmaceutical innovations, especially in the realm of antibiotics. His numerous patents and collaborations highlight his dedication to enhancing medical treatments and combating bacterial infections, positioning him as a valuable asset in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…